Clemessy J L, Taboulet P, Hoffman J R, Hantson P, Barriot P, Bismuth C, Baud F J
Réanimation Toxicologique, Hôpital F. Widal and Université de Paris, France.
Crit Care Med. 1996 Jul;24(7):1189-95. doi: 10.1097/00003246-199607000-00021.
To describe various aspects of prognostic and therapeutic importance in patients treated for acute chloroquine poisoning.
Retrospective study.
Toxicology intensive care unit (ICU) of a university hospital.
None.
One hundred sixty-seven consecutive patients with acute chloroquine overdose admitted to our toxicology ICU.
The mean amount ingested by history was 4.5 +2- 2.8 g. and 43 (26%) of 167 patients ingested > 5 g. The mean blood chloroquine concentration on admission was 20.5 +/- 13.4 mumol/L The majority (87%) of our patients received at least one arm of a combination therapy regimen (epinephrine, mechanical ventilation, diazepam). cardiac arrest occurred in 25 patients before hospital arrival; In seven of these patients, cardiac arrest occurred immediately after injection of thiopental. The mortality rate was 8.4% overall, and was 9.3% in patients with massive ingestions (NS vs. the group as a whole). We did not find a meaningful correlation between the amount ingested as estimated by history and the peak blood chloroquine concentration; the latter was highly correlated with the mortality rate.
The mortality rate in patients with acute chloroquine poisoning, including those patients sick enough to be referred to a specialty unit such as ours, can be limited to < or = 10%. This finding appears to be true even in patients with massive ingestions. We were not able to correlate mortality with amount ingested by history, although the mortality rate does correlate with blood chloroquine concentration. While early use of diazepam, epinephrine, and mechanical ventilation in most of our patients may have contributed to the excellent overall results, these elements, either singly or in combination, do not appear to have a truly antidotal effect in acute chloroquine poisoning. Thiopental, on the other hand, should be used with great caution, if at all, in such cases.
描述急性氯喹中毒患者预后及治疗方面的重要情况。
回顾性研究。
一所大学医院的毒理学重症监护病房(ICU)。
无。
167例连续入住我院毒理学ICU的急性氯喹过量患者。
据病史记录,平均摄入量为4.5±2.8克,167例患者中有43例(26%)摄入量超过5克。入院时氯喹的平均血药浓度为20.5±13.4微摩尔/升。大多数患者(87%)接受了至少一种联合治疗方案(肾上腺素、机械通气、地西泮)。25例患者在入院前发生心脏骤停;其中7例患者在注射硫喷妥钠后立即发生心脏骤停。总体死亡率为8.4%,大量摄入者的死亡率为9.3%(与整个研究组相比无显著差异)。我们未发现根据病史估计的摄入量与氯喹血药浓度峰值之间存在有意义的相关性;后者与死亡率高度相关。
急性氯喹中毒患者,包括那些病情严重到被转诊至我们这样的专科单位的患者,死亡率可控制在≤10%。即使是大量摄入者,这一结果似乎也成立。尽管死亡率与氯喹血药浓度相关,但我们未能将死亡率与根据病史记录的摄入量相关联。虽然大多数患者早期使用地西泮、肾上腺素和机械通气可能有助于取得良好的总体效果,但这些因素单独或联合使用,在急性氯喹中毒中似乎并没有真正的解毒作用。另一方面,在这种情况下,硫喷妥钠即使使用也应极其谨慎。